NDLI: $Bis(1,10-phenanthroline-κ^{2}$ N,N′)(sulfato-O)copper(II) butane-2,3-diol monosolvate

Please wait, while we are loading the content...

Year: 2014 Volume: 70

Year: 2013 Volume: 69

Year: 2013 Volume: 69 Issue: Part 12

Year: 2013 Volume: 69 Issue: Part 11

Year: 2013 Volume: 69 Issue: Part 10

Year: 2013 Volume: 69 Issue: Part 9

Year: 2013 Volume: 69 Issue: Part 8

Year: 2013 Volume: 69 Issue: Part 7

Year: 2013 Volume: 69 Issue: Part 6

Year: 2013 Volume: 69 Issue: Part 5

Year: 2013 Volume: 69 Issue: Part 4

Year: 2013 Volume: 69 Issue: Part 3

Year: 2013 Volume: 69 Issue: Part 2

Year: 2013 Volume: 69 Issue: Part 1

Sr–fresnoite determined from synchrotron X-ray powder diffraction data

$β-K(VO_{2})_{2}(PO_{4})$

$RbYb(PO_{3})_{4}$

$cis-Bis(2,2′-bipyridine-κ^{2}$ N,N′)carbonylchloridoruthenium(II) hexafluoridophosphate

Bis(ethanamidinium) (1,10-phenanthroline-2,9-dicarboxylato)manganate(II) heptahydrate

$Tris(1,10-phenanthroline-κ^{2}$ N,N′)iron(II) bis(1,1,3,3-tetracyano-2-ethoxypropenide) hemihydrate

$Carbonyl\{3,3′-di-tert-butyl-5,5′-dimethoxy-2,2′-bis[(4,4,5,5-tetramethyl-1,3,2-dioxaphospholan-2-yl)oxy]biphenyl-κ^{2}$ P,P′}hydrido(triphenylphosphane-κP)rhodium(I) diethyl ether trisolvate

$μ-Azido-κ^{2}$ N $^{1}:N$ $^{1}-μ-chlorido-bis[(2-chloro-3-dimethylamino-1-phenylprop-1-en-1-yl-κ^{2}$ C $^{1},N)palladium(II)]$ chloroform monosolvate

rac-(S,S)-Bis(1-ferrocenylbut-3-enyl) ether

Aqua(4-cyanopyridine-κN $^{4})(5,10,15,20-tetraphenylporphyrinato-κ^{4}$ N)magnesium

$Tetrakis[μ-2-(methoxycarbonyl)benzoato-κ^{2}$ O $^{1}:O$ $^{1′}]bis[(acetonitrile-κN)copper(II)](Cu—Cu)$

$Dichlorido\{N-[(5-methylthiophen-2-yl)methylidene]-2-(pyridin-2-yl)ethanamine-κ^{2}$ N,N′}palladium(II)

$catena-Poly[[tris(acetonitrile-κN)praseodymium(III)]tris(μ-trifluoromethanesulfonato-κ^{2}$ O:O′)]

$Poly[(μ_{6}-4-amino-3,5,6-trichloropyridine-2-carboxylato)aquacaesium]$

$Aqua\{2-(pyridin-2-yl)-N-[(pyridin-2-yl)methylidene]ethanamine-κ^{3}$ $N,N′,N′′\}(sulfato-κ^{2}$ O,O′)copper(II) tetrahydrate

$Bis(1,10-phenanthroline-κ^{2}$ $N,N′)(sulfato-κ^{2}$ O,O′)cobalt(II) propane-1,2-diol monosolvate

Dichlorido{(E)-4-dimethylamino-N′-[(pyridin-2-yl)methylidene-κN]benzohydrazide-κO}zinc

$(η^{6}-p-Cymene)(1,3-dimesityl-2,3-dihydro-1H-imidazol-2-ylidene)bis(pentafluorobenzoato-κO)ruthenium(II)$ dichloromethane disolvate

catena-Poly[[[O,O′-bis(2-methylphenyl) $dithiophosphato-κ^{2}$ S,S]lead(II)]-μ-O,O′-bis(2-methylphenyl) $dithiophosphato-κ^{3}$ S,S′:S]

$Bis(\{1-[(1-iminoethyl)imino]ethyl\}azanido-κ^{2}$ N $^{1},N$ $^{5})nickel(II)$ methanol monosolvate

$[2,6-Bis(5-ethoxy-1,3-oxazol-2-yl)-4-methoxyphenyl-κ^{3}$ N,C $^{1},N′]bromidopalladium(II)$

Tris[4-(dimethylamino)pyridinium] hexakis(thiocyanato-κN)ferrate(III) monohydrate

Chlorido[1H-1,2,4-triazole-5(4H)-thione-κS]bis(triphenylphosphane-κP)copper(I) acetronitrile monosolvate

(Benzyl isocyanide-κC $^{1})chlorido(2-chloro-3-dimethylamino-1-phenylprop-1-en-1-yl-κ^{2}$ C $^{1},N)palladium(II)$

$2,2,7,7,12,12,17,17-Octamethyl-21,22,23,24-tetrathia-2,7,12,17-tetragermapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-3,5,8,10,13,15,18,20-octaene$

Butan-1-aminium tetrachloridoferrate(III)–18-crown-6 (1/1)

Chlorido{N-[2-(diphenylphosphanyl)benzylidene]-2,6-diisopropylaniline-κP}gold(I) chloroform 0.25-solvate

$Hexa-μ_{2}-acetato-hexa-n-butylhexa-μ_{3}-oxido-tin(IV)$ toluene monosolvate

$Bis(1,10-phenanthroline-κ^{2}$ N,N′)(sulfato-O)copper(II) butane-2,3-diol monosolvate

Benzyltriphenylphosphonium dichloridotriphenylstannate(IV)

$catena-Poly[[tetrakis(hexamethylphosphoramide-κO)bis(nitrato-κ^{2}$ O,O′)erbium(III)] [silver(I)-di-μ-sulfido-tungstate(VI)-di-μ-sulfido]]

[μ-N $^{1},N$ $^{2}-Bis(pyridin-2-yl)hydrazine-1,2-dicarbothioamidato]bis[chloridocopper(II)]$

1,1′-Bis(tert-butyldimethylsilyl)ferrocene

A dimer of bis(N-heterocyclic carbene)rhodium(I) centres spanned by a dibenzo-18-crown-6 bridge from synchrotron radiation

$Dibromido(2,9-dimethyl-1,10-phenanthroline-κ^{2}$ N,N′)(dimethyl sulfoxide-κO)cadmium

$Bis[1-benzyl-2-(1,3-thiazol-4-yl)-1H-benzimidazole-κ^{2}$ N $^{2},N$ $^{3}]dichloridocobalt(II)$

$Hexakis(μ_{3}-2-hydroxynaphthalene-1-carboxaldehyde$ $thiosemicarbazonato-κ^{3}$ N $^{2}:S:S)hexasilver(I)$ N,N-dimethylformamide tetrasolvate

$Poly[[tetraaquadi-μ_{4}-fumarato-μ_{2}-oxalato-dierbium(III)]$ tetrahydrate]

Chlorido{[(E)-2-(diphenylphosphanyl)benzylidene](furan-2-ylmethyl)amine-κP}gold(I)

The mixed-valent copper thiolate complex $hexakis\{μ_{3}-2-[(1,3-dimethylimidazolidene)amino]benzenethiolato\}dicopper(II)tetracopper(I)$ bis(hexafluoridophosphate) acetonitrile disolvate dichloromethane disolvate

Redetermination of $cis-bis(ethylenediamine-κ^{2}$ N,N′)bis(nitrito-κN)cobalt(III) $(ethylenediamine-κ^{2}$ N,N′)tetrakis(nitrito-κN)cobaltate(III) monohydrate

$Tris(2,2′-bipyridine-κ^{2}$ N,N′)cobalt(II) bis(hexafluoridophosphate)

Bis(4,4′-sulfanediyldipyridinium) tetrachloridonickelate(II) dichloride

$catena-Poly[[[aqua(glycine-κO)lithium]-μ-glycine-κ^{2}$ O:O′] bromide]

$Poly[(μ_{4}-3-carboxypyrazine-2-carboxylato)(μ_{4}-nitrato)dilithium]$

$Tris(1,10-phenanthroline-κ^{2}$ N,N′)nickel(II) hexaoxido-μ-peroxido-disulfate(VI) N,N-dimethylformamide disolvate monohydrate

Bis[(1RS,2RS)-4,4′-(1-azaniumyl-2-hydroxyethane-1,2-diyl)dipyridinium] tris[tetrachloridopalladate(II)]

Diaquabis[4-(1H-imidazol-2-yl)pyridine-κN]bis(nitrato-κO)cadmium

$Bis[μ-bis(diphenylphosphanyl)methane-κ^{2}$ $P:P′](μ-1-ethylthiourea-κ^{2}$ S:S)bis[iodidocopper(I)] acetonitrile sesquisolvate

Potassium (1R,4R,5S,8S)-4,5,8-trihydroxy-3-oxo-2,6-dioxabicyclo[3.3.0]octane-4-sulfonate dihydrate

$(2-Amino-7-methyl-4-oxidopteridine-6-carboxylato-κ^{3}$ O $^{4},N$ $^{5},O$ $^{6})aqua(1,10-phenanthroline-κ^{2}$ N,N′)cobalt(II) trihydrate

Diaquabis(nitrato-κO)bis(pyridine-κN)manganese(II)

(9H-Fluoren-9-yl)(phenyl)phosphinic acid

9-(4-Hydroxy-3-methoxyphenyl)-3,3,6,6-tetramethyl-1,2,3,4,5,6,7,8,9,10-decahydroacridine-1,8-dione

9-(3-Fluorophenyl)-3,3,6,6-tetramethyl-1,2,3,4,5,6,7,8,9,10-decahydroacridine-1,8-dione

N,N′-(Pyridine-2,6-diyl)dibenzamide

(E)-5-[3-Cyano-2-(dicyanomethylene)-1-oxaspiro[4.5]dec-3-en-4-yl]-3-(1-methyl-1,4-dihydropyridin-4-ylidene)pent-4-en-1-yl 3,5-bis(benzyloxy)benzoate

2-Amino-7,7-dimethyl-5-oxo-4-[3-(trifluoromethyl)phenyl]-1,4,5,6,7,8-hexahydroquinoline-3-carbonitrile

1-{(Z)-[3-(1-Hydroxyethyl)anilino]methylidene}naphthalen-2(1H)-one

4-Bromo-2-[(E)-(2-fluoro-5-nitrophenyl)iminomethyl]phenol

2-(Adamantan-1-yl)-1,3-bis(4-methylphenyl)propan-2-ol

2-[Anilino(phenyl)methyl]cycloheptanone

2-[1-(2-Hydroxy-6-methoxyphenyl)ethylidene]-N-methylhydrazinecarbothioamide acetonitrile monosolvate

1,5-Bis(piperidin-1-yl)-9,10-anthraquinone

(E)-16-(4-Chlorobenzylidene)estrone

4-Methoxy-3-(methoxymethyl)benzaldehyde

(E)-2,4,6-Trimethyl-N-[(1H-pyrrol-2-yl)methylidene]aniline

1-(4-Nitrophenyl)-1H-imidazol-3-ium chloride

A second monoclinic polymorph of 4-[(E)-(4-benzyloxybenzylidene)amino]-1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one

6,12-Bis(hexyloxy)-5H,11H-indolo[3,2-b]carbazole

(Furfurylamino)triphenylphosphonium bromide

1-(Prop-2-ynyl)-1H-benzimidazol-2(3H)-one

Bosentan monohydrate.

2-[4-(2-{5-tert-Butyl-2-chloro-3-[2-(3-pentyl-1,3-benzothiazol-2-ylidene)ethylidene]cyclohex-1-enyl}ethenyl)-3-cyano-5,5-dimethylfuran-2-ylidene]malononitrile

1-(4-Methylbenzyl)-1H-benzimidazol-2(3H)-one

Methyl 4-(4-chlorophenyl)-8-iodo-2-methyl-6-oxo-1,6-dihydro-4H-pyrimido[2,1-b]quinazoline-3-carboxylate

4-(Prop-2-yn-1-yloxy)benzaldehyde

Triclinic polymorph of 4-[4-(4-formylphenoxy)butoxy]benzaldehyde

1,5-Dimethyl-2-phenyl-1H-pyrazol-3(2H)-one–4,4′-(propane-2,2-diyl)bis[1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one] (1/1)

2-[4-(Morpholin-4-ylmethyl)phenyl]benzonitrile

Ethyl (E)-3-(anthracen-9-yl)prop-2-enoate

2-Amino-5-methylpyridinium 2-hydroxy-5-chlorobenzoate

2-Amino-5-methylpyridinium 4-chlorobenzoate

1-{(Z)-[(2,3-Dihydroxypropyl)amino]methylidene}naphthalen-2(1H)-one

4-Cyano-N-ethylspiro[chromene-2,4′-piperidine]-1′-carboxamide

1-(2-Hydroxy-4,5-dimethoxyphenyl)ethanone

Cytosinium orotate dihydrate

rac-5′′-(4-Fluorobenzylidene)-1′-(4-fluorophenyl)-1′′-methyl-1′,2′,3′,5′,6′,7′,8′,8a′-octahydrodispiro[acenaphthylene-1,3′-indolizine-2′,3′′-piperidine]-2,4′′(1H)-dione

Cinnarizinium fumarate

(R,R)-1-Acetyl-1′-(2,4,6-trinitrophenyl)-2,2′-bipyrrolidine

[2,7-Dimethoxy-8-(4-methoxybenzoyl)naphthalen-1-yl](4-methoxyphenyl)methanone chloroform monosolvate

1-{2-Benzyloxy-2-[4-(morpholin-4-yl)phenyl]ethyl}-1H-benzimidazole

1,1,3,3-Tetra-tert-butyl-2,2-diisopropyl-4,4-diphenylcyclotetrasilane

1-(2-Chlorobenzoyl)-3-(2-trifluoromethylphenyl)thiourea

5-(Prop-2-yn-1-yl)-5H-dibenzo[b,f]azepine: orthorhombic polymorph

(E)-3-Dimethylamino-1-(1,3-thiazol-2-yl)prop-2-en-1-one

1-(2-Chlorobenzoyl)-3-(3-methoxyphenyl)thiourea

Stable polymorph of $morphine^{1}$

(Biphenyl-2,2′-diyl)di-tert-butylphosphonium trifluoromethanesulfonate

(±)-3-Benzyloxy-1-(4-methoxybenzyl)piperidine-2-thione

2,2′-({4-[(4-Nitrophenyl)diazenyl]phenyl}imino)diethanol

Ethyl $27-oxo-15-oxa-2,20-diazahexacyclo[18.6.1.0^{1,8}.0^{2,6}.0^{9,14}.0^{21,26}]heptacosa-9,11,13,21,23,25-hexaene-7-carboxylate$

Ethyl $8,13-dioxa-21-azapentacyclo[18.5.1.0^{2,7}.0^{14,19}.0^{21,25}]hexacosa-2(7),3,5,14,16,18-hexaene-26-carboxylate$

[2-(3,4-Dimethylbenzoyl)phenyl](4-methoxyphenyl)methanone

1-{(Z)-1-(2,4-Dichlorophenyl)-1-[2-(4-methylphenoxy)ethoxy]prop-1-en-2-yl}-1H-imidazol-3-ium nitrate

(E)-2-(4-Chlorophenoxy)-N′-(pyridin-4-ylmethylidene)acetohydrazide

Anilinium-3-carboxylate 3-carboxyanilinium nitrate

N,N-Diethylanilinium 5-(2,4-dinitrophenyl)-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-olate

3-Chloro-2,4,5-trifluorobenzoic acid

N,N,2,4,6-Pentamethylanilinium hexafluorophosphate

4,6-Dimethylpyrimidin-2-amine

Dichlorophosphinic bis(2-chloroethyl)amide

2,6-Dichloroaniline–4-(2,6-dichloroanilino)pent-3-en-2-one (1/2)

6-Phenylbenzo[d]naphtho[2,3-b]thiophene

(2E,2′E)-1,1′-Bis(6-chloro-2-methyl-4-phenylquinolin-3-yl)-3,3′-(1,4-phenylene)diprop-2-en-1-one ethyl acetate disolvate

2-(2,4-Dichlorophenyl)-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)acetamide

Ethyl 2,7,7-trimethyl-4-(1-methyl-1H-indol-3-yl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate

8-Hydroxy-5,7-dimethylquinolin-1-ium hydrogen sulfate

8-Hydroxy-5,7-dimethylquinolin-1-ium chloride dihydrate

7-[(Morpholin-4-yl)(phenyl)methyl]quinolin-8-ol

2-(2,6-Dichlorophenyl)-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)acetamide

11,12-Dichlorodibenzo[a,c]phenazine

1,3-Diethyl-2-sulfanylidene-5-(2,4,5-trimethoxybenzylidene)-1,3-diazinane-4,6-dione

2-(4-Methoxyphenyl)-1-pentyl-4,5-diphenyl-1H-imidazole

2,2-Dimethyl-5-(2-nitrobenzylidene)-1,3-dioxane-4,6-dione

3-Hydroxy-1-(4-methoxybenzyl)piperidin-2-one

N-[3a-(4-Bromophenyl)-8b-hydroxy-6,8-dimethoxy-3-phenyl-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-1-yl]formamide monohydrate

(Z)-Ethyl 2-hydroxy-4-oxo-4-(1,4,5,6,8-pentamethoxynaphthalen-2-yl)but-2-enoate

4-Methoxybenzamidinium bromide

Glycine–phthalic acid (1/1)

3-{3,5-Bis[(2-butoxyethoxy)carbonyl]-2,6-dimethyl-1,4-dihydropyridin-4-yl}-1-[(3,4,5-trimethoxybenzoyl)methyl]pyridinium bromide

17β-Hydroxy-17α-methylandrosta-1,4-dien-3-one

2-[(E)-2-Hydroxy-3-methoxybenzylidene]-N-methylhydrazinecarbothioamide

2-(1-Phenyl-1H-benzimidazol-2-yl)phenol

(3E,5E)-3,5-Bis(2-chlorobenzylidene)-1-propylpiperidin-4-one

2-Hydroxy-4-(prop-2-ynyloxy)benzaldehyde

4-(5-Chlorothiophen-2-yl)-1,2,3-selenadiazole

6-(3-Chlorophenyl)imidazo[2,1-b][1,3,4]thiadiazole

1-[4-({4-[(E)-(2-Hydroxynaphthalen-1-yl)methylideneamino]phenyl}sulfanyl)phenyl]ethanone

6-Phenyloxane-2,4-dione

N-(4-Chlorophenyl)-4-nitrobenzenesulfonamide

[2-(1,3-Benzothiazol-2-ylmethoxy)-5-bromophenyl](4-chlorophenyl)methanone

(8-Benzoyl-2,7-diethoxynaphthalen-1-yl)(phenyl)methanone

(Z)-1-Chloro-1-[2-(2-nitrophenyl)hydrazinylidene]propan-2-one

1-O-Acetyl-3,4,6-tri-O-benzyl-2-C-bromomethyl-2-deoxy-α-d-glucopyranose

2-[(3-Oxo-1-benzofuran-6-yl)oxy]acetonitrile

2-{[(Dimethylamino)methylidene]amino}-5-nitrobenzonitrile

N-(2,3-Dichlorophenyl)-2-nitrobenzenesulfonamide

3,5-Bis[(pyridin-4-yl)methoxy]benzoic acid

(E)-2-Phenyl-N-tosylnon-2-en-4-ynamide

1-Methoxy-11H-benzo[b]fluoren-11-one

N-(2,5-Dimethoxyphenyl)-6-nitroquinazolin-4-amine

$14-Ethoxy-4,6-dimethyl-9-phenyl-8,12-dioxa-4,6-diazatetracyclo[8.8.0.0^{2,7}.0^{13,18}]octadeca-2(7),13,15,17-tetraene-3,5,11-trione$

Diphenylmethyl benzoate

6-Ethoxycarbonyl-5,7-dihydroxy-2,3-dihydro-1H-pyrido[3,2,1-ij]quinolinium tribromide

4-(4-Iodoanilino)-2-methylene-4-oxobutanoic acid

1-(2-Chlorobenzoyl)-3-(pyrimidin-2-yl)thiourea

9-(3-Bromo-5-chloro-2-hydroxyphenyl)-10-(2-hydroxyethyl)-1,2,3,4,5,6,7,8,9,10-decahydroacridine-1,8-dione

Triphenyl[(triphenylphosphoranylidene)amino]phosphonium tetrakis(pentafluorophenyl)borate

2,2,7,7-Tetramethyl-1,2,3,4,5,6,7,8-octahydroacridine-1,8-dione

(2S,3R,4S,4aR)-2,3,4,7-Tetrahydroxy-3,4,4a,5-tetrahydro[1,3]dioxolo[4,5-j]phenanthridin-6(2H)-one hemihydrate

1-{(E)-[5-(2-Nitrophenyl)furan-2-yl]methylidene}-2,2-diphenylhydrazine

(E)-2-Hydroxy-4-methoxy-3-(3-methylbut-2-enyl)-6-styrylbenzoic acid

2,3-Diaminopyridinium hydrogen malonate

2-Amino-5-methylpyridinium 4-methylbenzoate

4-Nitrophenyl 2-chlorobenzoate

Triethylammonium 4-(3,5-dinitrobenzamido)-N-(3,5-dinitrobenzoyl)benzenesulfonamidate

N-(Diphenylcarbamoyl)-N,N′,N′,N′′,N′′-pentamethylguanidinium tetraphenylborate

rac-Ethyl 2-hydroxy-2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-3,4,5,6,7,8-hexahydro-2H-chromene-3-carboxylate

Year: 2012 Volume: 68

Year: 2009 Volume: 66

Year: 2009 Volume: 65

Year: 2008 Volume: 65

Year: 2008 Volume: 64

Year: 2007 Volume: 64

$Bis(1,10-phenanthroline-κ^{2}$ N,N′)(sulfato-O)copper(II) butane-2,3-diol monosolvate

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Cao, Guo-qing Zhong, Kai-long
Description	Author Affiliation: Zhong KL ( Department of Applied Chemistry, Nanjing College of Chemical Technology, Nanjing 210048, People's Republic of China.)
Abstract	The title compound, $[Cu(SO_{4})(C_{12}H_{8}N_{2})_{2}]·C_{4}H_{10}O_{2},$ is comprised of neutral monomeric complex and butane-2,3-diol solvent molecules. In the complex, the $Cu^{II}$ ion is in a distorted square-pyramidal coordination environment defined by four N atoms from two chelating 1,10-phenanthroline ligands and one O atom from a monodentate sulfate anion; the O atom is at the apex. The two chelating $N_{2}C_{2}$ groups subtend a dihedral angle of 85.8 (4)°. In the crystal, the neutral monomeric complex and butane-2,3-diol solvent molecules are held together by O—H⋯O hydrogen bonding, which leads to additional stabilization of the structure. The presence of pseudosymmetry in the structure suggests the higher symmetry space group C2/c, but attempts to refine the structure in this space group resulted in an unsatisfactory model and high R and wR values. The sulfate anion is disordered over two sets of sites with occupancies of 0.55 (1) and 0.45 (1).
ISSN	20569890
e-ISSN	16005368
Journal	Acta Crystallographica Section E Structure Reports Online
Issue Number	Pt 1
Volume Number	69
Language	English
Publisher	IUCr/Wiley
Publisher Date	2013-01-01
Publisher Place	United States
Access Restriction	Open
Subject Keyword	Crystallography
Content Type	Text
Resource Type	Article
Subject	Chemistry Condensed Matter Physics Materials Science

Central Library (ISO-9001:2015 Certified)
Indian Institute of Technology Kharagpur
Kharagpur, West Bengal, India | PIN - 721302

See location in the Map
03222 282435
Mail: support@ndl.gov.in

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in